Management of cardiovascular risk in primary prevention: real-world data

被引:0
|
作者
Danchin, N. [1 ]
Puymirat, E. [1 ]
Vedrenne, G. [1 ]
Durand, E. [1 ]
机构
[1] Hop Europeen Georges Pompidou, Dept Cardiol, 20 Rue Leblanc, F-75015 Paris, France
关键词
Primary prevention; Statins; Antihypertensive agents; Tobacco ban; Diabetes; Obesity;
D O I
10.1016/S1878-6480(12)70843-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tremendous progress in the management of cardiovascular risk in the general population has been accomplished over the past two decades, resulting in a decreased incidence of severe cardiovascular conditions such as myocardial infarction, and in a dramatic reduction in cardiovascular mortality. In particular, the management of hypertension and hyperlipidaemia have notably improved. Among public health measures, the smoking ban has been largely successful, while nutritional campaigns and the fight against sedentary behaviours have given mixed results, with continuing growth in the proportion of overweight and obese individuals in the general population. It is therefore essential that recent efforts at prevention are pursued to ensure that the incidence of cardiovascular disease will not rise again in the future. (C) 2012 Elsevier Masson SAS. All rights reserved.
引用
下载
收藏
页码:279 / 283
页数:5
相关论文
共 50 条
  • [1] Statins for the primary prevention of cardiovascular diseases: An Asian real-world perspective
    Calabria, Silvia
    Maggioni, Aldo Pietro
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 375 : 12 - 13
  • [2] Real-world data show the effect of statins in primary prevention
    Mariampillai, Julian E.
    Kjeldsen, Sverre E.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 30 (17) : 1881 - 1882
  • [3] CARDIOVASCULAR RISK WITH GNRH AGONISTS AND ANTAGONISTS: REAL-WORLD DATA FROM UK PRIMARY CARE
    Davey, Patrick
    Kirby, Michael
    JOURNAL OF UROLOGY, 2020, 203 : E250 - E251
  • [5] REAL-WORLD DATA MANAGEMENT
    VANRENSSELAER, C
    COMPUTER DECISIONS, 1988, 20 (10): : 50 - 53
  • [6] Statin utilization and cardiovascular outcomes in a real-world primary prevention cohort of older adults
    Walker, Aaron J.
    Zhu, Jianhui
    Thoma, Floyd
    Marroquin, Oscar
    Makani, Amber
    Gulati, Martha
    Gianos, Eugenia
    Virani, Salim S.
    Rodriguez, Fatima
    Reis, Steven E.
    Ballantyne, Christie
    Mulukutla, Suresh
    Saeed, Anum
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 18
  • [7] Real-World Battles with Real-World Data
    Brown, Jeffrey
    Bate, Andrew
    Platt, Robert
    Raebel, Marsha
    Sauer, Brian
    Trifiro, Gianluca
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 254 - 255
  • [8] Global Cardiovascular Risk Management in Primary Prevention
    Volpe, Massimo
    Tocci, Giuliano
    CURRENT VASCULAR PHARMACOLOGY, 2012, 10 (06) : 709 - 711
  • [9] Real-world study: from real-world data to real-world evidence
    Wen, Yi
    TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
  • [10] Management of atherosclerosis risk factors for patients at high cardiovascular risk in real-world practice: a multicentre study
    Phrommintikul, Arintaya
    Krittayaphong, Rungroj
    Wongcharoen, Wanwarang
    Yamwong, Sukit
    Boonyaratavej, Smonporn
    Kunjara-Na-Ayudhya, Rapeephon
    Tatsanavivat, Pyatat
    Sritara, Piyamitr
    SINGAPORE MEDICAL JOURNAL, 2017, 58 (09) : 535 - 542